An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Bibliografske podrobnosti
Glavni avtor:	Bristy, Israt Zerin
Drugi avtorji:	Kabir, Md. Tanvir
Format:	Thesis
Jezik:	English
Izdano:	Brac University 2021
Teme:	Covid-19 Lung carcinoma Genetic mutation Chemotherapy Immunotherapy Lungs > Cancer Oncology
Online dostop:	http://hdl.handle.net/10361/15619

Podobne knjige/članki

Molecules associated with the development of lung cancer
od: Rahman, Adree, et al.
Izdano: (2023)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
od: Shabnam, Musharrat
Izdano: (2018)

Immunotherapy in the Management of Lung Cancer
od: Tasnim, Humayra
Izdano: (2022)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
od: Paul, Pulock
Izdano: (2024)

Potential of liposomes for the treatment of lung cancer- a review
od: Mim, Shanzida
Izdano: (2023)

Protein biomarkers for Lung Cancer: a bioinformatic approach
od: Jeba, Joynob
Izdano: (2017)

A review on recent advances in drugs for lung cancer treatment
od: Noor, Fouzia
Izdano: (2024)

A review on targeted therapies for lung cancer
od: Ashraf, Anushey
Izdano: (2023)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
od: Zangmo, Thinley
Izdano: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
od: Tania, Umme
Izdano: (2023)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
od: Rahman, Sanjida
Izdano: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
od: Rahman, Tasnim
Izdano: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
od: Razna, Amrin Islam
Izdano: (2019)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
od: Hoque, Ismoth Ara
Izdano: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
od: Pial, Sazia Afrin
Izdano: (2018)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
od: Mukti, Roushney Fatima, et al.
Izdano: (2016)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Flora, Sanzida Alam
Izdano: (2024)

Immunotherapy in the treatment of renal cancer
od: Shimu, Sumaya
Izdano: (2022)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
od: Das, Reshita
Izdano: (2024)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
od: Abir, Shifaty Nur
Izdano: (2024)

Lung cancer detection and classification using machine learning
od: Arefin, Mahbubul, et al.
Izdano: (2023)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
od: Nandy, Aditi
Izdano: (2022)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
od: F. S. Amaral, André, et al.
Izdano: (2017)

Current practice and approaches of immunotherapy in Cancer treatment
od: Khondokar, Faiza
Izdano: (2022)

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): A localized drug delivery approach to treat peritoneal carcinomatosis of different origins
od: Afrin, Sabrina
Izdano: (2023)

Semantic segmentation with attention dense U-net for lung extraction from X-ray images
od: Auvy, Akib Al Mahmud, et al.
Izdano: (2023)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Karim, Samia Binte
Izdano: (2024)

Deep 3D convolutional neural network in early detection of Lung cancer
od: Hossain, Khandoker Jobayer, et al.
Izdano: (2019)

A review on CRISPR-Cas system based applications in Oncology
od: Sadia, Mir
Izdano: (2022)

Smart biomedical device to predict lung diseases, COVID-19 and diabetes by using machine learning algorithms
od: Hossain, Ashraful, et al.
Izdano: (2024)

Pulmonary patient compliance among different types of inhaler dosage forms in Mohakhali, Dhaka
od: Rithin, Rafia Islam
Izdano: (2022)

Hypothesizing precise cancer treatments based on patient survival using machine learning & deep learning
od: Sakib, Hasibul, et al.
Izdano: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
od: Mirza, Maisa Tasnim
Izdano: (2023)

CAR-T cell Therapy in B-cell Lymphoma
od: Faruk, Asef
Izdano: (2020)

Effect of passive immunization with mouse Anti-BCG 64 kDa protein on ehrlich ascites carcinoma cells
od: Chowdhury, Maisha Mosharrat
Izdano: (2018)

Dendritic cell vaccine for the treatment of cancer
od: Haque, Tanzila
Izdano: (2023)

Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis
od: Monayem, Kazi Fahim
Izdano: (2024)

The uses of bacteria in cancer therapy
od: Saha, Shimul, et al.
Izdano: (2021)

A review paper on Nanotechnology based strategies in the treatment of cancer
od: Rahman, Samia
Izdano: (2022)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
od: Raihan, Dilraj
Izdano: (2024)